Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TPEX/4157 stock hub

TPEX/4157 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4157is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.7B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4157

In the news

Latest news · TPEX/4157

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E157.5

P25 14.4P50 18P75 31.9

ROE4.2

P25 -16.2P50 0.3P75 9.8

ROIC52.1

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4157 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

TWD

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	TW
Enterprise value	TWD 5.7B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG866171005
Last refreshed	2026-05-10
Market cap	TWD 6.7B
Price	TWD 9.45
Price currency	TWD
Sector	Healthcare
Sic	2836
Symbol	tpex/4157
Website	https://www.taigenbiotech.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.67%
EV Earnings	127.26x
EV/EBIT	82.85x
EV/EBITDA	66.27x
EV/FCF	295.12x
EV/Sales	22.16x
FCF yield	0.29%
P/B ratio	6.26x
P/E ratio	157.5x
P/S ratio	25.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.74%
EBITDA Margin	28.16%
FCF margin	7.51%
Gross margin	93%
Gross Profit	TWD 241.3M
Gross Profit Growth	79.38%
Gross Profit Growth Q	3,613%
Gross Profit Growth3 Y	95.1%
Gross Profit Growth5 Y	65.58%
Net Income	TWD 45.2M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	22.14%
Profit Margin	17.41%
Profitable Years	1
ROA	3.7
Roa5y	6.24
ROCE	6.4
ROE	4.19
Roe5y	16.78
ROIC	52.08
Roic5y	7.03

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.88%
Cagr1y	-5.22%
Cagr3y	-15.65%
Cagr5y	-16.04%
EPS Growth Quarters	2
EPS Growth Years	1
FCF Growth Q	76%
OCF Growth Q	78.35%
Revenue Growth	72.24x
Revenue Growth Q	2,104.37x
Revenue Growth Quarters	1x
Revenue Growth Years	3x
Revenue Growth3 Y	92.76x
Revenue Growth5 Y	61.77x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.22
Assets	TWD 1.2B
Cash	TWD 1B
Current Assets	TWD 1.1B
Current Liabilities	TWD 83.1M
Debt	TWD 49.2M
Debt EBITDA	TWD 0.57
Debt Equity	TWD 0.05
Debt FCF	TWD 2.53
Equity	TWD 1.1B
Interest Coverage	41.68
Liabilities	TWD 92.4M
Long Term Assets	TWD 47.3M
Long Term Liabilities	TWD 9.3M
Net Cash	TWD 977.5M
Net Cash By Market Cap	TWD 14.53
Net Cash Growth	1.71%
Net Debt EBITDA	TWD -13.38
Net Debt Equity	TWD -0.91
Net Debt FCF	TWD -50.18
Tangible Book Value	TWD 1.1B
Tangible Book Value Per Share	TWD 1.48
WACC	5.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.48
Inventory Turnover	0.31
Net Working Capital	TWD 50.7M
Quick ratio	12.51
Working Capital	TWD 1B
Working Capital Turnover	TWD 0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-64.67%
1Y total return	-5.22%
200-day SMA	10.52
3Y total return	-40%
50-day SMA	11
50-day SMA vs 200-day SMA	50over200
5Y total return	-58.28%
All Time High	74.5
All Time High Change	-87.32%
All Time High Date	2013-10-31
All Time Low	7.44
All Time Low Change	27.02%
All Time Low Date	2025-07-24
ATR	0.31
Beta	0.24
Beta1y	0.22
Beta2y	0.53
Ch YTD	-29.48
High	9.84
High52	16.4
High52 Date	2026-01-09
High52ch	-42.38%
Low	9.44
Low52	7.44
Low52 Date	2025-07-24
Low52ch	27.02%
Ma50ch	-14.11%
Price vs 200-day SMA	-10.13%
RSI	28.53
RSI Monthly	40.77
RSI Weekly	39.27
Sharpe ratio	0.12x
Sortino ratio	0.34
Total Return	0.19%
Tr YTD	-29.48
Tr1m	-15.63%
Tr1w	-4.74%
Tr3m	-23.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 69.4M
Operating margin	26.74

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	432,304,521%
Net Borrowing	24,299,000
Shares Insiders	2.63%
Shares Institutions	2.53%
Shares Out	711,833,575
Shares Qo Q	-0.5%
Shares Yo Y	-0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 31.1M
Average Volume	1,344,625.2x
Bv Per Share	1.51
CAPEX	TWD -1.4M
Ch10y	-64.67
Ch1m	-15.63
Ch1w	-4.74
Ch1y	-5.22
Ch3m	-23.48
Ch3y	-40
Ch5y	-58.28
Ch6m	3.39
Change	-2.78%
Change From Open	-2.78
Close	9.72
Days Gap	0
Depreciation Amortization	3,666,000
Dollar Volume	16,199,832.6
Earnings Date	2026-05-13
EBIT	TWD 69.4M
EBITDA	TWD 73.1M
EPS	TWD 0.06
F Score	5
FCF	TWD 19.5M
FCF EV Yield	0.34x
FCF Per Share	TWD 0.03
Financing CF	-34,641,000
Fiscal Year End	December
Founded	2,001
Graham Number	1.42777
Graham Upside	-84.89
Income Tax	TWD 12.3M
Investing CF	83,371,000
Is Primary Listing	1
Last Earnings Date	2025-11-12
Last Report Date	2025-12-31
Ma150	11.06
Ma150ch	-14.58%
Ma20	10.24
Ma20ch	-7.71%
Net CF	70,951,000
Next Earnings Date	2026-05-13
Open	9.72
P FCF Ratio	345.3
P OCF Ratio	321.4
Position In Range	2.5
Ppne	17,314,000
Price Date	2026-05-08
Price EBITDA	TWD 92.07
Ptbv Ratio	6.39
Relative Volume	1.32x
Revenue	259,474,000x
SBC By Revenue	-4.48x
Share Based Comp	-11,630,000
Tax By Revenue	4.73x
Tax Rate	21.35%
Tr6m	3.39%
Volume	1,714,268
Z Score	48.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/4157 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/4157 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4157?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.5%

Share of float held by funds and institutions

Insider ownership

+2.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

TPEX/4157 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.5

Below 30: short-term oversold

Price vs 200-day MA

-10.1%

50/200-day relationship not available

Beta (5Y)

0.24

Less volatile than the market

Sharpe ratio

0.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4157

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4157 stock rating?

tpex/4157 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4157 analysis?

The full report lives at /stocks/tpex/4157/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4157?

The latest report frames tpex/4157 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4157 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.